Kirkland Advises Zymeworks on Acquisition of Theravance
June 29, 2026
June 29, 2026
CHICAGO, Illinois, June 29 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, issued the following news release:
* * *
Kirkland Advises Zymeworks on Acquisition of Theravance
*
Kirkland & Ellis advised Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics, on a definitive agreement to acquire Theravance Bi . . .
* * *
Kirkland Advises Zymeworks on Acquisition of Theravance
*
Kirkland & Ellis advised Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics, on a definitive agreement to acquire Theravance Bi . . .